Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: GN465U8B72

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-31 receptor subunit alpha inhibitor PubMed PubMed
Primary Target
Interleukin-31 receptor, α subunit

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dermatitis, Atopic 3 D003876 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1476039-58-3
ChEMBL CHEMBL4297794
FDA SRS GN465U8B72
Guide to Pharmacology 8720